AI is a Must-Have for Life Sciences Commercial Teams: Aktana CEO David Ehrlich Interviewed on The Bio Report

October 22, 2019/Aktana/Decision Support

Applying machine learning and artificial intelligence (AI) to the commercial process in the biopharmaceutical industry is rapidly becoming a critical success factor in organizations. In a recent interview on The Bio Report podcast, Aktana CEO and President David Ehrlich sat down with host Danny Levine to discuss how intelligent technology is closing the loop between […]

Intelligent Engagement in the LatAm Market: Q&A with Eduardo Alonso, Aktana Head of Customer Success

The Veeva Commercial Summit in Sao Paulo is right around the corner, and we’re getting ready by sitting down with one of the newest members of our customer success team, Eduardo Alonso. With 21 years experience working at major pharmaceutical companies and consulting firms in Brazil, Eduardo has a wealth of insight about the current […]

Novartis and Aktana at Veeva Summit: Building the AI-Driven Commercial Engagement Model

May 30, 2019/Lauren Schivley/Events

We returned as a platinum sponsor once again to the Veeva Commercial and Medical Summit, which welcomed over 1,700 attendees in Philadelphia this year. At the event, Eva Martins, Global Head of Innovative Models and Commercial Transformation at Novartis, and Derek Choy, Co-founder and COO at Aktana, presented how Novartis is partnering with Aktana to […]

Three Principles of Agile HCP Engagement

The demand for AI-driven personalization and cohesive experiences across channels is prompting a change in go-to-market execution. Healthcare providers (HCPs) are demanding a more connected experience. It’s important, now more than ever, for commercial teams to shift away from the traditional annual, cycle-driven execution model to more a more frequent, agile approach. This will help […]

Industry Leaders Come Together to Discuss Intelligent Customer Engagement at the 2019 Aktana Innovators Forum

We recently hosted our annual Aktana Innovators Forum in New York City. The event brought together life sciences leaders for a series of discussions about the role of artificial intelligence (AI) in the new commercial model. 2019 will be a transformative year for many life sciences companies and the forum offered opportunities to connect with […]

A view from Japan: Helping reps better understand customer needs

March 27, 2019/Aktana/Field Sales

Meeting the expectations of healthcare providers (HCPs) should be obvious, but often this sentiment is easier said than done, especially in the life sciences industry. The complex landscape of this market in Japan makes this task even more challenging, filled with complicated regulations, contracts, and various stakeholders. How can we ensure our reps are providing […]

The Democratization of Machine Learning in Commercial Life Sciences

Machine learning is easily one of the most heavily discussed buzzwords within life sciences in the past few years. Defined as a process where large amounts of data and algorithms give a machine the ability to learn how to perform tasks and identify patterns, it often gets a bad rap. Although there are clear benefits […]

The Essential Role of In-House Analytics

Across industries, innovators are finding ways to use data and analytics to be disruptive. This combination fuels the need for organizations to have advanced data capabilities in order to stay competitive. Many life sciences companies aim to meet this challenge by tapping the resources and expertise of their in-house analytics teams. However, these teams can […]

Novartis’s Intelligent “Personal Assistant” Facilitates More Meaningful HCP Interactions

Life sciences organizations are continuing to adopt digital technologies as the industry experiences a digital revolution. With the incredible amounts of data set to be captured in 2019, artificial intelligence (AI) and machine learning are changing the industry landscape. Novartis CEO Vas Narasimhan discusses in a recent article how strategic technology partnerships are enabling acceleration […]

Four AI trends making commercial life sciences smarter in 2019

February 12, 2019/Erik Loos/Blog

Artificial intelligence (AI) has already proved to be useful when it comes to life sciences R&D, starting to fruitfully aid in plumbing the vast depths of discovery, clinical, and real-world data. However, the benefits of AI are now making themselves known on the business side of the life sciences industry, enabling commercial teams to better understand and address the needs of the healthcare providers and patients they serve. In 2019, the following trends will help to define how AI can become better integrated into the commercial side of life sciences businesses.